|
|
|
|
DiaMedBase ID
|
|
DMPAp056 |
|
Medicinal Plant
|
|
Andrographis paniculata |
|
Plant part(s)
|
|
Leaves
|
|
Objective
|
|
To study the antihyperglycemic action
of andrographolide |
|
Journal Source
|
|
Planta
Med.
2003; 69(12):1075-1079 |
|
Title
|
|
Antihyperglycemic effect of
andrographolide in streptozotocin-induced diabetic rats. |
|
Authors
|
|
Yu BC, Hung CR, Chen WC, Cheng JT |
|
Address
|
|
Department of Pharmacology, College of
Medicine, National Cheng Kung University, Tainan City, Taiwan |
|
Abstract
|
|
The antihyperglycemic action of
andrographolide, an active principle in the leaves of Andrographis
paniculata (Burm. f.) Nees, was investigated in streptozotocin-induced
diabetic rats (STZ-diabetic rats). Oral treatment of andrographolide
decreased the plasma glucose concentrations of STZ-diabetic rats in a
dose-dependent manner. Similar treatment with andrographolide also
decreased the plasma glucose in normal rats and the maximal effect was
more marked than that in STZ-diabetic rats. Andrographolide at the
effective dose (1.5 mg/kg) significantly attenuated the increase of
plasma glucose induced by an intravenous glucose challenge test in
normal rats. In the isolated soleus muscle of STZ-diabetic rats,
andrographolide enhanced the uptake of radioactive glucose in a
concentration-dependent manner. Moreover, the mRNA and protein levels
of the subtype 4 form of the glucose transporter (GLUT4) in soleus
muscle were increased after repeated intravenous administration of
andrographolide in STZ-diabetic rats for 3 days. These results suggest
that andrographolide can increase the glucose utilization to lower
plasma glucose in diabetic rats lacking insulin. |
|
Diseases |
|
Disease Link |
|
DiaMedBase ID |
|
DMPAp057 |
|
Medicinal Plant
|
|
Andrographis
paniculata |
|
Plant part(s)
|
|
Whole plant |
|
Objective |
|
To reduce the fasting serum glucose
level in STZ-diabetic rats |
|
Journal Source
|
|
Acta
Pharmacol Sin,
2000; 21(12):1157-1164 |
|
Title
|
|
Anti-diabetic property of ethanolic
extract of Andrographis paniculata in streptozotocin-diabetic rats |
|
Authors
|
|
Zhang XF, Tan BK |
|
Address
|
|
Department of Pharmacology, Faculty of
Medicine, National University of Singapore, Singapore 117597,
Singapore |
|
Abstract
|
|
To investigate the anti-diabetic effect
of a crude ethanolic extract of Andrographis paniculata in normal and
streptozotocin (STZ)-induced diabetic rats. Oral administration of the
extract at different doses (0.1, 0.2, and 0.4 g/body weight)
significantly reduced the fasting serum glucose level in STZ-diabetic
rats compared to the vehicle (distilled water), but not in normal
rats. This effect was dose-dependent. A similar result was seen with
metformin (0.5 g/body weight). In the glucose tolerance test, an oral
administration of the extract at the same doses suppressed the
elevated glucose level in normal and diabetic rats, as did metformin.
The effects were also dose-respondent. In the long-term experiment,
the extract (0.4 g/body weight), metformin (0.5 g/body weight), and
vehicle were given twice daily to diabetic rats for 14 d. On d 15,
fasting serum glucose levels were found to be significantly lower in
the extract- and metformin-treated groups (P < 0.001) than in the
vehicle-treated group. The mean food and water intakes over 14 days
were significantly lower in the extract-treated group (P < 0.05, P <
0.01, respectively) and also in the metformin-treated group (both P <
0.001) when compared to the vehicle-treated group. No significant
change in insulin level was observed among the 3 groups of diabetic
rats. The extract, like metformin, maintained the leptin levels after
14-d treatment, whereas this level was significantly decreased (P <
0.05) in the vehicle-treated group. The activity of hepatic
glucose-6-phosphatase (G-6-Pase) was significantly reduced by the
extract as well as by metformin (both P < 0.05). No significant
difference in hepatic glycogen stores was noted among the 3 groups.
The extract caused 49.8% reduction of fasting serum triglyceride
levels, compared to 27.7% with metformin. However, neither the extract
nor metformin significantly affected serum cholesterol level. The
ethanolic extract of A paniculata possesses antidiabetic property. Its
antidiabetic effect may be attributed at least in part to increased
glucose metabolism. Its hypotriglyceridemic effect is also beneficial
in the diabetic state. |
|
Diseases |
|
Disease Link |

|